BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17868195)

  • 1. Modafinil and nicotine interactions in abstinent smokers.
    Sofuoglu M; Waters AJ; Mooney M
    Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
    Sofuoglu M; Babb D; Hatsukami DK
    Nicotine Tob Res; 2003 Dec; 5(6):947-53. PubMed ID: 14668079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
    Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G
    Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokers.
    Sofuoglu M; Mouratidis M; Yoo S; Kosten T
    Behav Pharmacol; 2006 Dec; 17(8):731-5. PubMed ID: 17110799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ; Fisher DJ
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.
    Turner DC; Clark L; Dowson J; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2004 May; 55(10):1031-40. PubMed ID: 15121488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of modafinil and nicotine, alone and in combination, in tobacco-deprived young adult smokers.
    Martin CA; Lile J; Guenthner G; Anestis JC; Batten SR; Kelly TH
    J Clin Psychopharmacol; 2014 Apr; 34(2):278-81. PubMed ID: 24525639
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome.
    Randall DC; Cafferty FH; Shneerson JM; Smith IE; Llewelyn MB; File SE
    J Psychopharmacol; 2005 Nov; 19(6):647-60. PubMed ID: 16272188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
    Cousins MS; Stamat HM; de Wit H
    Nicotine Tob Res; 2001 May; 3(2):123-9. PubMed ID: 11403726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
    Sofuoglu M; Poling J; Mouratidis M; Kosten T
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):645-51. PubMed ID: 16432681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.
    Sofuoglu M; Mouratidis M; Yoo S; Culligan K; Kosten T
    Psychopharmacology (Berl); 2005 Sep; 181(3):504-10. PubMed ID: 15983800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive enhancing effects of modafinil in healthy volunteers.
    Turner DC; Robbins TW; Clark L; Aron AR; Dowson J; Sahakian BJ
    Psychopharmacology (Berl); 2003 Jan; 165(3):260-9. PubMed ID: 12417966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study.
    Gill M; Haerich P; Westcott K; Godenick KL; Tucker JA
    Acad Emerg Med; 2006 Feb; 13(2):158-65. PubMed ID: 16436796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.